Ruti Aga's Six-Year Ban: A Fake Prescription From a Clinic That Never Existed

That March morning, the half marathon course sat on the edge of a Chinese city, asphalt still damp from overnight rain. The footfalls sounded steady, like the breathing of a machine already wound. Ruti Aga won. No grandstand, no international broadcast, nobody counting her kilometres online. After the prize ceremony the result simply sat in a PDF on the organiser's website, waiting to be taken down.

Then another envelope arrived, from the Athletics Integrity Unit.

Inside was a six-year ban. And inside that ban was a prescription slip.

I read the notice four times, and each time I stopped at the same place. The prescription was written on an old pad from a clinic; the signatory claimed to have worked there, and the clinic confirmed no one by that name had ever appeared on its staff list. The clinic printed on the slip did not exist. The signatory was a family member with no medical registration.

A world-class marathoner, a Tokyo champion, closed her own career with a piece of paper so clumsily forged it was close to a confession.

Placing her on the map

Ruti Aga is 32, Ethiopian. In 2026 she won the Tokyo Marathon, one of the six World Marathon Majors — the most prestigious road races on the planet. She also finished runner-up at Majors events three times. For a female marathoner, that record places her among the elite of world road running across the 2026–2026 window.

The race that triggered the case was far humbler: a half marathon in China, held in March. The AIU notice gives no performance mark for it. No finishing time, nothing to measure against a personal best, a course profile or any reference point. Technically, all I can log is: a win, with no data attached.

That race sits inside a very particular economy of distance running. Half marathons and marathons across Asia, China especially, pay appearance fees to East African athletes large enough to sustain a professional for a full year. These races have no press room with a hundred reporters. There is money, there is a course, there are tens of thousands of mass runners behind, and there is a small group of Kenyan and Ethiopian athletes at the front racing for the title.

Stars are not born in finals; they are born in races nobody watches. But it is precisely on those unwatched courses that testing is thinner and temptation is thicker.

The adjudicating body is the Athletics Integrity Unit, World Athletics' independent integrity arm, responsible for testing, results management and prosecution. The case was resolved under the WADA Code, not under a race organiser's rules. That detail decides who may pass sentence and who may appeal.

A substance called by the wrong name

Methylprednisolone is a synthetic glucocorticoid — a corticosteroid, an anti-inflammatory. Much of the coverage called it a steroid, and that label distorts the entire severity calculation.

In WADA's list, glucocorticoids sit in class S9, prohibited in-competition only. Out of season, the same injection creates no violation. It is also a Specified Substance — a category the Code acknowledges is more plausibly linked to inadvertent or therapeutic use. The legal consequence is concrete: the baseline sanction is two years, not four, and the athlete has a pathway to show the use was not intentional.

That is the softer half of the case. And because it is soft, the rest becomes hard to explain.

Aga said she used the substance to treat a knee injury. Medically, that is a scenario so ordinary it is almost banal: glucocorticoids are injected into knees to reduce inflammation in distance runners, and sports physicians routinely warn each other about timing before a race. Had that been all, the story would have ended as a therapeutic misadventure handled badly.

A legal route existed, and it was not difficult. Obtain a Therapeutic Use Exemption before competing. Or, if the injection happened out of competition and a sample came back positive, disclose it fully, produce the medical file, and let the panel consider a no-fault finding. An athlete with competent medical support does not stumble at both steps.

Aga stumbled. But she did not stumble alone.

The prescription with no clinic

This is the part that turns the case into a governance lesson rather than a routine doping item.

Asked to explain, Aga produced a prescription to prove the methylprednisolone was treatment. The AIU checked it the standard way: it called the clinic named on the paper, cross-referenced the signatory against staff records, and checked professional registration.

Layer by layer, it collapsed.

The clinic did not exist. The signatory was a relative with no medical registration. The relative claimed to have used an old prescription pad from a former workplace; that workplace confirmed the person had never been on staff. The clinic named on the slip confirmed the prescription was not theirs.

Four verification layers, four identical outcomes.

The striking part: the case was not cracked by a laboratory, but by a phone call. A positive sample only opens a question. The forged document is what closed the case, and it closed faster than any analytical process could. In nine years of watching the roads, I have not seen a case that demonstrates more clearly how forged paperwork has become the most easily dismantled form of evidence in the anti-doping system.

The arithmetic: two plus four

The structure of the sanction almost writes itself: two years for the presence of a prohibited substance, four years for tampering with evidence during results management, served consecutively. The WADA Code provides that separate violations are served back-to-back, not concurrently. There is no offset mechanism.

Look at the ratio and one thing is unmistakable: the penalty for the cover-up is twice the penalty for the offence being covered up.

For an athlete at the top, that inversion is the whole story. Had Aga told the truth about the knee injection, she most likely faced a two-year sanction, possibly reduced further on a no-fault finding, and could have returned at 34 as an athlete who had served a ban but still had a career. She chose otherwise, and the price was four extra years plus the loss of any claim to having made a therapeutic error.

In this system, paperwork fraud is treated more harshly than biological fraud. That is deliberate. If athletes can fabricate documents, the entire TUE architecture collapses, because nothing can be verified. Protecting the authenticity of the file protects the mechanism. Aga became the example of that principle.

Age thirty-two and age thirty-eight

The ban runs from 10 September. The starting year is not stated in the notice, so I log it as data pending verification rather than inferring it.

Age, however, is certain. Aga is 32. For female marathoners the peak window commonly extends to 35 and beyond. She was in the middle of it, not past it. A six-year ban returns her at roughly 38, after six years without competition, without racing conditions, without a race to sustain motivation.

A female marathoner can absolutely compete at 38. Competing at World Marathon Majors level after six years away is a different proposition. In my memory of long bans in athletics, almost no case has returned at the previous level. The body does not hold that foundation across six years, and more importantly, nobody waits.

Competitively, this is a career-ending sanction, not a suspension.

A replaceable node

Ethiopian and Kenyan women's road running is the deepest system in the sport. Dozens of athletes run under 2:25 each season, and a slot in a major championship line-up can be filled within weeks.

Aga was an important node in that system, but still a replaceable one. Her removal barely shifts the competitive balance of women's marathoning. Nobody adjusts tactics because she is absent.

What is damaged is a different asset: the brand credibility of East African road running. Agents, organisers and sponsors buy the image of a clean athletics culture, and every case like this devalues it. Yet even that loss is diffuse — it spreads across the system rather than landing on any individual.

The unwatched road

Where nobody is looking, I find the thing the world will later talk about. Here, what I found was an economic structure that pushes East African athletes toward races with low testing density.

Asian half marathons pay appearance fees, winner's purses, sometimes advertising contracts. An athlete can race four or five times a season in different cities, a week at a time, earning far more than a place in a major final. But these races have no medical infrastructure, no permanent anti-doping staff, and nobody to remind an athlete that yesterday's painkilling injection will still be in her body on race day.

That gap is not the fault of a country. It is the fault of a model: money flows where the spectators are, while responsibility stays anchored where the paperwork is.

The contrarian read: the verdict is right, and only half right

The easiest reaction is to nod. She cheated, then she forged documents, six years is fair. I do not dispute the conclusion. It just stops too early.

Look at how the forgery was assembled and something other than a sophisticated doping plot appears. Clumsiness appears. A clinic name that does not exist. An old prescription pad. A relative with no licence who believed a stamped piece of paper would be enough. No lawyer, no integrity adviser, nobody to say that the AIU would call the clinic within days.

That clumsiness is a diagnosis. It says that around a world-class athlete there was no professional buffer thick enough to handle a crisis. She had a coach, an agent, a system that carried her to Tokyo. But at the moment she needed someone who knew the rules, she called her family.

And here is the harder point: the anti-doping system is extraordinarily effective at catching paperwork errors and extraordinarily poor at preventing them. The AIU's verification is flawless. Nobody checked whether a 32-year-old Ethiopian athlete understood what a Specified Substance is before she signed that slip.

People doubted me with a look; I answered with a whole race. In 2026, aged 16, I sat in the commentary box for an U19 match at Lach Tray and was asked flatly what a girl knows about tactics. I misread the Guam number 7's name three times in the first half. That night I watched twelve qualifiers and charted every formation. The first headset was heavier than I expected, but my voice was heavier still.

I tell that story for one concrete reason: when nobody has your back, one mistake costs everything. Aga had nobody behind her. She made one mistake and lost six years.

What I do not want is for this to be read as proof of a systemic problem in Ethiopian athletics. The record shows an individual case, handled clumsily, inside a development system so deep it feeds the world. The distance between a family forging a document and an organised doping programme is enormous. Blurring the two is laziness.

What remains after the paper

Six years is long enough for an athlete to vanish from memory, and short enough that her name resurfaces every time a new forgery case appears.

In the annual season, where everything is measured by standings and finishes, I still keep a habit of noting what never reaches the table. A forged prescription does not appear in a results list. But it explains why certain names disappear from the roads before anyone thinks to ask.

With no cheers around, I hear my own applause more clearly. And on courses without spectators, I hear more clearly than anyone the sound of a career closed by an old prescription pad.

Sport teaches that discipline is self-imposed. But where nobody stands behind you, discipline needs scaffolding: someone who knows the law, a medical protocol, an honest answer given before the question is asked. When that scaffolding is missing, punishment arrives in its place — and punishment does not distinguish between the deliberate cheat and the person who never learned how to protect herself.